NGVT vs IOSP

For growth investors, Innospec Inc.

(IOSP) is the stronger pick with -3. 7% revenue growth year-over-year, versus -17. 0% for Ingevity Corporation (NGVT). Innospec Inc. (IOSP) offers the better valuation at 18. 5x trailing P/E (17. 9x forward), making it the more compelling value choice. Analysts rate Ingevity Corporation (NGVT) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Ingevity Corporation is actually cheaper at 14.

6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Innospec Inc.

(IOSP) delivered a total return of -4. 2%, compared to -10. 8% for Ingevity Corporation (NGVT). Over 10 years, the gap is even starker: NGVT returned +111. 0% versus IOSP's +105. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Innospec Inc.

(IOSP) is the lower-risk stock at 0. 70β versus Ingevity Corporation's 1. 27β — meaning NGVT is approximately 83% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 42% for Ingevity Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Innospec Inc.

(IOSP) is pulling ahead at -3. 7% versus -17. 0% for Ingevity Corporation (NGVT). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to 61. 1% for Ingevity Corporation. Over a 3-year CAGR, IOSP leads at -3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Innospec Inc.

(IOSP) is the more profitable company, earning 6. 6% net margin versus -14. 3% for Ingevity Corporation — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NGVT leads at 22. 4% versus 8. 8% for IOSP. At the gross margin level — before operating expenses — NGVT leads at 39. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Ingevity Corporation (NGVT) trades at 14.

6x forward P/E versus 17. 9x for Innospec Inc. — 3. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 32. 8% to $115. 00.

In this comparison, IOSP (2.

0% yield) pays a dividend. NGVT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Innospec Inc.

(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 0% yield, +105. 2% 10Y return). Both have compounded well over 10 years (IOSP: +105. 2%, NGVT: +111. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

IOSP pays a dividend while NGVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.